Embryonic stem cells offer new treatment for multiple sclerosis

(University of Connecticut) A novel approach to treating multiple sclerosis using human embryonic stem cells appears to offer better treatment results than stem cells derived from human adult bone marrow, scientists in the University of Connecticut's Technology Incubation Program say.